ContextVertebral fractures significantly increase lifetime risk of future fractures, but risk of
further vertebral fractures in the period immediately following a vertebral fracture has not been …

Background. To determine the effects of etidronate (a bisphosphonate that inhibits
osteoclast-mediated bone resorption) in the treatment of postmenopausal osteoporosis, we …

Purpose: To review the literature on the effects of amiodarone on thyroid physiology and
management of amiodarone-induced thyroid disease. Data Sources: English-language articles …

The relationship between early changes in biochemical markers of bone turnover and the
subsequent BMD response to daily teriparatide therapy in women with postmenopausal …

… Angelo A Licata Angelo A Licata MD PhD FACP, Consultant, Metabolic Bone Center;
Research Director, Department of Endocrinology, The Cleveland Clinic Foundation, 1063 Kirtland …

purpose: To determine the effect of long-term intermittent cyclic etidronate treatment on
spinal bone density and vertebral fracture rates. patients and methods: Postmenopausal …

Bone loss in the lower extremities and lumbar spine is an established consequence of long-duration
human space flight. Astronauts typically lose as much bone mass in the proximal …

Alendronate (ALN) is an aminobisphosphonate employed as an antiresorptive agent in the
treatment of osteoporosis. The present study was carried out to determine dose-response …

Objective To determine whether hip fracture patients, a group at very high risk for additional
fragility fractures, are being evaluated and treated effectively for osteoporosis. Methods …

2. METHODS The AACE Board of Directors mandated a CPG on healthy eating for the
prevention and treatment of metabolic and endocrine diseases in adults. The project was …